Skip to content

The effect of slow releasing carbohydrates on the variability of plasma amino acid concentrations in PKU-patients in childhood.

The effect of slow releasing carbohydrates on the variability of plasma amino acid concentrations in PKU-patients in childhood. - Slow releasing carbohydrates and Phenylketonurie

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31050
Enrollment
6
Registered
2008-12-19
Start date
2007-11-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aangeboren stofwisselingsziekte Phenylalanine hydroxylase deficiency

Interventions

Addition of SRC or FRC to the 3d portion of amino-acid supplementation at bedtime: the additional carbohydrates will be diluted in the fluid amino acid supplement with some extra water. When the ami

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: They are in good metabolic control, defined as a blood Phe concentration measurement within the target range of 120-360 µmol/l (Dutch PKU Advice Committee) one month prior to the study period. Apart from the PKU the patients are in a healthy state during the study periods. Their growth figures are within +/- 2 SD of the national growth charts. Patients take their amino acid supplementation divided into three portions each day. Participants / parents or caretakers are capable of routinely home skin puncturing without problems.

Exclusion criteria

Exclusion criteria: Blood Phe concentrations frequently beyond the target range, bad compliance in intake of the amino acid mixture, growth retardation > -2SD, obesity > +2SD, insufficient knowledge of the Dutch language of the caretaker, not taking blood samples at home

Design outcomes

Primary

MeasureTime frame
Differences in blood Phe concentrations (and other amino acids?) between early morning (A) and end of the day (B) in the two study periods under the different conditions (without intervention, with SRC and with SRC) will be compared.

Secondary

MeasureTime frame
Relationship between the severity of the disease defined as the individual Phe tolerance at 5 years of age, and the resulting mean and SD of blood Phe concentrations of each period will be tested with univariate linear regression analysis (ANOVA).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)